Griffithsin carrageenan fast dissolving inserts prevent SHIV HSV-2 and HPV infections in vivo

Human immunodeficiency virus (HIV) pre-exposure prophylaxis (PrEP) strategies with proven in vivo efficacy rely on antiretroviral drugs, creating the potential for drug resistance and complicated treatment options in individuals who become infected. Moreover, on-demand products are currently missing...

Descripción completa

Detalles Bibliográficos
Autores principales: Derby, Nina, Lal, Manjari, Aravantinou, Meropi, Kizima, Larisa, Barnable, Patrick, Rodriguez, Aixa, Lai, Manshun, Wesenberg, Asa, Ugaonkar, Shweta, Levendosky, Keith, Mizenina, Olga, Kleinbeck, Kyle, Lifson, Jeffrey D., Peet, M. Melissa, Lloyd, Zachary, Benson, Michael, Heneine, Walid, O’Keefe, Barry R, Robbiani, Melissa, Martinelli, Elena, Grasperge, Brooke, Blanchard, James, Gettie, Agegnehu, Teleshova, Natalia, Fernández-Romero, José A., Zydowsky, Thomas M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6155161/
https://www.ncbi.nlm.nih.gov/pubmed/30250170
http://dx.doi.org/10.1038/s41467-018-06349-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6155161/
https://www.ncbi.nlm.nih.gov/pubmed/30250170
http://dx.doi.org/10.1038/s41467-018-06349-0

Ejemplares similares